Xponance, Inc. Gilead Sciences, Inc. Transaction History

Xponance, Inc.

$10.2 Billion
Q3 2024

A detailed history of Xponance, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Xponance, Inc. holds 193,952 shares of GILD stock, worth $17.5 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

193,952

Previous 194,941 0.51%

Holding current value

$17.5 Million

Previous $13.4 Million 21.56%

% of portfolio

0.16%

Previous 0.14%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$66.59 - $83.99 $65,857 - $83,066	-989 Reduced 0.51%	193,952 $16.3 Million
Q2 2024 Aug 14, 2024	SELL	$63.15 - $72.88 $63,150 - $72,880	-1,000 Reduced 0.51%	194,941 $13.4 Million
Q1 2024 May 13, 2024	BUY	$71.58 - $87.29 $679,866 - $829,080	9,498 Added 5.09%	195,941 $14.4 Million
Q4 2023 Jan 31, 2024	BUY	$73.27 - $83.09 $1 Million - $1.14 Million	13,667 Added 7.91%	186,443 $15.1 Million
Q3 2023 Oct 23, 2023	BUY	$73.94 - $80.67 $122,888 - $134,073	1,662 Added 0.97%	172,776 $12.9 Million
Q2 2023 Jul 13, 2023	SELL	$76.01 - $86.7 $94,328 - $107,594	-1,241 Reduced 0.72%	171,114 $13.2 Million
Q1 2023 Apr 17, 2023	BUY	$77.31 - $88.08 $282,181 - $321,492	3,650 Added 2.16%	172,355 $14.3 Million
Q4 2022 Jan 23, 2023	BUY	$62.32 - $89.47 $1.2 Million - $1.73 Million	19,312 Added 12.93%	168,705 $0
Q3 2022 Oct 24, 2022	BUY	$59.54 - $68.01 $2.36 Million - $2.69 Million	39,581 Added 36.04%	149,393 $9.22 Million
Q2 2022 Aug 02, 2022	BUY	$57.72 - $65.01 $1.1 Million - $1.24 Million	19,081 Added 21.03%	109,812 $6.79 Million
Q1 2022 Apr 20, 2022	BUY	$57.92 - $72.58 $259,771 - $325,521	4,485 Added 5.2%	90,731 $5.39 Million
Q4 2021 Jan 31, 2022	BUY	$64.88 - $73.64 $1.25 Million - $1.42 Million	19,343 Added 28.91%	86,246 $6.26 Million
Q3 2021 Nov 05, 2021	SELL	$67.69 - $73.03 $410,336 - $442,707	-6,062 Reduced 8.31%	66,903 $4.67 Million
Q2 2021 Aug 12, 2021	SELL	$63.47 - $69.35 $2.29 Million - $2.51 Million	-36,147 Reduced 33.13%	72,965 $5.02 Million
Q1 2021 May 10, 2021	BUY	$60.0 - $68.46 $35,820 - $40,870	597 Added 0.55%	109,112 $7.05 Million
Q4 2020 Feb 11, 2021	BUY	$56.65 - $64.55 $53,987 - $61,516	953 Added 0.89%	108,515 $6.32 Million
Q3 2020 Oct 26, 2020	SELL	$62.1 - $78.08 $735,636 - $924,935	-11,846 Reduced 9.92%	107,562 $6.8 Million
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $8.64 Million - $10 Million	119,408 New	119,408 $9.19 Million

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.

Account